FDA
- Status: approved
Corifollitropin alfa and menotropin (Corifollitropin alfa and menotropin) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology is the originator. The local marketing authorisation holder may differ — check the official source linked above.